Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 9, 2008 11:10:36 AM CDT

Learn about Newser Points »

Back to the grid

Stents Show No Lasting Benefit In Heart Study

Posted Mar 27, 07 8:17 AM CDT in Science & Health    Editor's Choice

(Newser) – Stents used to open arteries are no more useful than conventional drug treatment for patients who haven't yet had a heart attack, a new study reveals. In more than 2,000 patients over five years, those who had surgery suffered the same number of heart attacks, strokes, and deaths as those received only drugs.

The one benefit to angioplasty? A reduction in chest pain symptoms, which also diminishes over time. Stent makers point out that the study didn't look at the new generation of medicated stents. Also, stents are still the best option for patients who have already had heart attacks, rather than those hoping to stave them off.

Source Los Angeles Times

Related News

  • Sir Paul Denies Heart Surgery

    Jan 31, 08 4:00 PM CST
    Sir Paul Denies Heart Surgery Sir Paul McCartney has publicly denied claims that he was hospitalized for heart surgery, NME reports. Earlier this month, the Sun reported that the legendary former Beatle had undergone a coronary angioplasty. But today, McCartney reassured fans and friends on his website that he had simply been tested for a "minor irregularity," and that he was in fine health. More »

  • Exercise + Alcohol = Good for Heart Health

    Jan 10, 08 1:04 PM CST
    Exercise + Alcohol = Good for Heart Health Moderate drinking may help you live longer, according to a new study by Danish researchers. Scientists followed 12,000 participants for 20 years and found that, regardless of how much they exercised, those who drank in moderation were about 30% less likely to develop heart disease than teetotalers. Physically active drinkers saw 50% less risk than non-active non-drinkers. More »

  • Study: Hospitals Too Slow to Shock Hearts

    Jan 2, 08 7:42 PM CST
    Study: Hospitals Too Slow to Shock Hearts American hospitals are taking too long to revive the hearts of patients who suffer cardiac arrest, a study finds. Electric shock from a defibrillator can restart a stopped heart, but only if it is done quickly. The American Heart Association recommends that patients in cardiac arrest receive treatment within two minutes, but 30% wait longer, the Wall Street Journal reports. More »

  • New Blood Thinner Tops Plavix in Trials

    Nov 5, 07 9:00 AM CST
    New Blood Thinner Tops Plavix in Trials An experimental new blood-thinner looks like real competition for top-selling anti-clotting drug Plavix, after proving more effective at preventing heart attacks, strokes, and heart-related death in a recent trial, the AP reports. But “there is a price to pay” for increased effectiveness, wrote one doctor—the new drug caused an extra bleeding death for each heart-related one it prevented. More »

  • The Anti-Heart-Attack Diet

    Oct 9, 07 4:35 PM CDT
    Preventing heart disease is about more than fad diets; it's about creating long-term change and sticking with it. Forbes gives you the no-nonsense guide to heart health:

    1. Balance calorie intake and activity.
    2. Eat fruits and veggies.
    3. Make sure at least half your carbs come from whole grains and high-fiber foods.
    More »

Heart print   ((c) zophos)
prev    next
play

Threads (1 of 2)

Tags

health  • medicine  • heart disease  • heart attack  • heart  • stents  • angioplasty


Loading...

Loading...

Related Threads: Pharma Misbehaving, Heart Health

Next story from this section »

Today's Most Popular


Other Home Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »